Epic Deterioration Index May Identify High- and Low-Risk COVID-19 Patients
The Epic Deterioration Index (EDI) can identify subsets of high- and low-risk patients with coronavirus disease 2019 (COVID-19).
News
LATEST NEWS
Pulmonary Embolism Prevalence in Hospitalized Patients With COPD
Patients with COPD who were hospitalized for acutely worsening respiratory symptoms had a prevalence of pulmonary embolism of 5.9%.
Priority Review Granted to Novel Pneumococcal Conjugate Vaccine V114
The V114 vaccine candidate consists of pneumococcal polysaccharides from 15 serotypes, including serotypes 22F and 33F, which are associated with invasive pneumococcal disease.
Cow’s Milk Intake While Breastfeeding May Reduce Child Food Allergies
Children whose mothers drink more cow’s milk during breastfeeding are at a lower risk for developing food allergies.
Mental Health Consequences of COVID-19 Identified Across Populations
Short-term mental health consequences of COVID-19 are equally high across affected countries and across gender.
Racial Disparities in Lung Cancer: Part 3 of a Special Series
In part 3 of this series, we interviewed Samuel Cykert, MD, who helped build a system-based intervention to reduce racial gaps and improve care for all patients with lung cancer.
Pulmonary Arterial Hypertension Identified in Administrative Data Using Collection of Algorithms
A collection of algorithms for detecting pulmonary arterial hypertension in administrative data has been developed to enhance the integrity and value of research findings and improve quality of care.
Pfizer-BioNTech COVID-19 Vaccine Elicits Response Against Key Mutation
The study was conducted by Pfizer and the University of Texas Medical Branch.
UPCOMING MEETINGS
NOVEMBER 7
Annual New York Lung Cancer Symposium
Virtual | New York, NY
NOVEMBER 13-15
American College of Allergy, Asthma & Immunology (ACAAI) 2020 Annual Scientific Meeting
Virtual | Phoenix, AZ
DRUG NEWS FROM MPR
Cemiplimab Granted Priority Review for Advanced NSCLC
COVID-19 Vaccines: AstraZeneca Resumes Trial; Pfizer, BioNTech Look to Expand Study
AstraZeneca Pauses COVID-19 Vaccine Trials
Additional Presentations of Ready-to-Use Premixed Vancomycin Bags Approved
Breztri Aerosphere Approved as Triple-Combination Therapy Inhaler for COPD
Immune Responses Observed in All Participants Dosed With COVID-19 Vaccine Candidate
Combined Long-Acting Bronchodilator Therapy Compared With Monotherapy for COPD
Brigatinib Approved as First-Line Treatment for ALK-Positive Metastatic NSCLC
Umbilical Cord Stem Cell Therapy to Be Assessed in Severe COVID-19
FDA: Scammers Continue to Sell Unproven Products for COVID-19
Drug Shortages Reported as New Program Created to Expedite Treatments for COVID-19
FDA Approves Imfinzi for Extensive-Stage Small Cell Lung Cancer
FDA: Studies Underway to Evaluate Chloroquine for COVID-19
Pirfenidone Gets Breakthrough Therapy Status for Unclassifiable Interstitial Lung Disease
FDA: Cases of Respiratory Depression With Gabapentinoids Reported
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in News
